Dual-targeting inhibition of TNFR1 for alleviating rheumatoid arthritis by a novel composite nucleic acid nanodrug

Dual-targeting inhibition of TNFR1 for alleviating rheumatoid arthritis by a novel composite nucleic acid nanodrug

Selective suppression of tumor necrosis factor (TNF) α-TNF receptor 1 (TNFR1) signaling is a potent solution for rheumatoid arthritis (RA). Herein, novel composite nucleic acid nanodrugs that simultaneously restrain TNF α binding and TNFR1 multimerization were designed to reinforce inhibition of TNF...

Full description

Bibliographic Details
Main Authors: Xiaonan Wang, Fanfan Guo, Yi Zhang, Ziyi Wang, Jiaqi Wang, Rongrong Luo, Xiao Chu, Yongxing Zhao, Pengchao Sun
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:International Journal of Pharmaceutics: X
Subjects:
Aptamer
Anti-inflammatory peptide
Tumor necrosis factor receptor 1
Nanodrug
Rheumatoid arthritis
Online Access:http://www.sciencedirect.com/science/article/pii/S2590156723000063

Internet

http://www.sciencedirect.com/science/article/pii/S2590156723000063

Similar Items